Licensing deal signed with Tepnel Life Sciences
- Two year agreement supports Abcam’s range of kits and other non-antibody products
| Over 500 kits now available |
 |
Abcam has extended its global licensing agreement with Tepnel Life Sciences. The two year deal means that Abcam will continue to distribute Tepnel’s Diaclone range of products to scientists worldwide.
The agreement supports Abcam’s growing range of non-antibody products, which now includes proteins, peptides, kits, slides and lysates.
Read more about Abcam’s proteins and peptides
Read more about Abcam’s range of ELISA, ELISPOT and ELIPAIR kits
